The US Air Force Research Lab 711th Human Performance Wing seeks a partner to commercialize a novel therapeutic design principle with the potential to rapidly respond to emergent infectious diseases
You are here
Medical & Biotechnology
The US Naval Research Laboratory seeks a partner to license and commercialize a novel technology that utilizes quantum dots to illuminate glass pipettes for use in targeted deep tissue and neuronal electrophysiology experiments
The United States Air Force seeks a partner to license and commercialize a novel break away needle to facilitate rapid, safe and streamlined vascular access.
The US Air Force seeks a partner to license and commercialize a live, attenuated vaccine against tularemia.
The US Air Force seeks a partner to license and commercialize a novel medical device for the the precise location of catheters and similar interventional devices.
The US Air Force seeks a partner to license and commercialize an endovascular variable aortic control (EVAC) catheter for resuscitative occlusion of arteries and control of blood flow during life-threatening hemorrhage
The US Army seeks a partner to license and commercialize a standardized system to attach a wide array of surgical and medical products and devices to a stretcher or litter
The US Army Natick Soldier-RDEC seeks partners to commercialize a novel method for rapidly, controllably, and safely generating aqueous chlorine dioxide from inexpensive, dry reagents for spray-on or rinse disinfectant applications
The US Air Force seeks to commercialize through patent licensing a trauma specific vascular injury shunt to restore blood flow to an injured extremity until definitive vascular repair can be accomplished.
The 59th Medical Wing conducted the research to develop the original technology and is the USAF
partner for advanced development to field this technology.
The US Army Geospatial Research Laboratory has developed and seeks to license a patent-pending, man-portable system for water purification with electro-chlorination, UV sanitation, and remote water monitoring capabilities
The US Army Research Institute of Infectious Diseases has developed a method to eliminate immunoassay inconsistency due to background effects. Immunological-based assays, such as ELISA (planar) or bead-based, suspension microsphere assays, are plagued with background issues. Almost all clinical and environmental samples will generate a background signal, and this signal can vary tremendously from sample to sample.
The US Army seeks a partner to license and commercialize a smartphone app that provides personalized predictions of cognition and alertness with the unique capability to predict the effects of naps and caffeine
The US Navy seeks a partner to license and commercialize pyriproxyfen formulations that improve transportability and deposition at the insect nesting site even in locations with high heat and relative humidity
The US Army has developed an energy storing ankle/foot orthosis and a high intensity, progression-oriented rehabilitation program proven to return severely injured patients back to a high level of activity.
The US Naval Research Laboratory seeks a partner to license and commercialize an innovative technique that provides real-time and label-free imaging of cellular protein secretions using commercially available microscopes